메뉴 건너뛰기




Volumn 69, Issue 5, 2017, Pages 658-666

Cystatin C–Guided Vancomycin Dosing in Critically Ill Patients: A Quality Improvement Project

Author keywords

antimicrobial dose regimen; creatinine; critically ill patients; cystatin C; dosing algorithm; estimated glomerular filtration rate (eGFR); goal trough concentration; intensive care unit (ICU); methicillin resistant Staphylococcus aureus (MRSA); pharmacokinetics; quality improvement project; renal function; sepsis; Vancomycin

Indexed keywords

CREATININE; CYSTATIN C; VANCOMYCIN; ANTIINFECTIVE AGENT;

EID: 85010402371     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2016.11.016     Document Type: Article
Times cited : (63)

References (40)
  • 1
    • 85017805884 scopus 로고    scopus 로고
    • Lake Forest, IL: Hospira, Inc;:1-8.
    • 1 Vancomycin full prescribing information. Lake Forest, IL: Hospira, Inc; 2011:1-8.
    • (2011)
  • 2
    • 84856176691 scopus 로고    scopus 로고
    • Incidence of nephrotoxicity and association with vancomycin use in intensive care unit patients with pneumonia: retrospective analysis of the IMPACT-HAP Database
    • 2 Cano, E.L., Haque, N.Z., Welch, V.L., et al. Incidence of nephrotoxicity and association with vancomycin use in intensive care unit patients with pneumonia: retrospective analysis of the IMPACT-HAP Database. Clin Ther 34 (2012), 149–157.
    • (2012) Clin Ther , vol.34 , pp. 149-157
    • Cano, E.L.1    Haque, N.Z.2    Welch, V.L.3
  • 3
    • 84864609103 scopus 로고    scopus 로고
    • Effects of targeting higher vancomycin trough levels on clinical outcomes and costs in a matched patient cohort
    • 3 Kullar, R., Davis, S.L., Taylor, T.N., Kaye, K.S., Rybak, M.J., Effects of targeting higher vancomycin trough levels on clinical outcomes and costs in a matched patient cohort. Pharmacotherapy 32 (2012), 195–201.
    • (2012) Pharmacotherapy , vol.32 , pp. 195-201
    • Kullar, R.1    Davis, S.L.2    Taylor, T.N.3    Kaye, K.S.4    Rybak, M.J.5
  • 4
    • 1042276996 scopus 로고    scopus 로고
    • Clinical features associated with bacteremia due to heterogeneous vancomycin-intermediate Staphylococcus aureus
    • 4 Charles, P.G.P., Ward, P.B., Johnson, P.D.R., Howden, B.P., Grayson, M.L., Clinical features associated with bacteremia due to heterogeneous vancomycin-intermediate Staphylococcus aureus. Clin Infect Dis 38 (2004), 448–451.
    • (2004) Clin Infect Dis , vol.38 , pp. 448-451
    • Charles, P.G.P.1    Ward, P.B.2    Johnson, P.D.R.3    Howden, B.P.4    Grayson, M.L.5
  • 5
    • 59749104464 scopus 로고    scopus 로고
    • Vancomycin ototoxicity: a reevaluation in an era of increasing doses
    • 5 Forouzesh, A., Moise, P.A., Sakoulas, G., Vancomycin ototoxicity: a reevaluation in an era of increasing doses. Antimicrob Agents Chemother 53 (2009), 483–486.
    • (2009) Antimicrob Agents Chemother , vol.53 , pp. 483-486
    • Forouzesh, A.1    Moise, P.A.2    Sakoulas, G.3
  • 6
    • 84903643749 scopus 로고    scopus 로고
    • Serum cystatin C predicts vancomycin trough levels better than serum creatinine in hospitalized patients: a cohort study
    • 6 Frazee, E.N., Rule, A.D., Herrmann, S.M., et al. Serum cystatin C predicts vancomycin trough levels better than serum creatinine in hospitalized patients: a cohort study. Crit Care, 18, 2014, R110.
    • (2014) Crit Care , vol.18 , pp. R110
    • Frazee, E.N.1    Rule, A.D.2    Herrmann, S.M.3
  • 7
    • 33744527833 scopus 로고    scopus 로고
    • Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock
    • 7 Kumar, A., Roberts, D., Wood, K.E., et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 34 (2006), 1589–1596.
    • (2006) Crit Care Med , vol.34 , pp. 1589-1596
    • Kumar, A.1    Roberts, D.2    Wood, K.E.3
  • 8
    • 84873339299 scopus 로고    scopus 로고
    • Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012
    • 8 Dellinger, R.P., Levy, M.M., Rhodes, A., et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 41 (2013), 580–637.
    • (2013) Crit Care Med , vol.41 , pp. 580-637
    • Dellinger, R.P.1    Levy, M.M.2    Rhodes, A.3
  • 9
    • 84930421453 scopus 로고    scopus 로고
    • Cost-effectiveness analysis of acute kidney injury biomarkers in pediatric cardiac surgery
    • 9 Petrovic, S., Bogavac-Stanojevic, N., Lakic, D., et al. Cost-effectiveness analysis of acute kidney injury biomarkers in pediatric cardiac surgery. Biochem Med (Zagreb) 25 (2015), 262–271.
    • (2015) Biochem Med (Zagreb) , vol.25 , pp. 262-271
    • Petrovic, S.1    Bogavac-Stanojevic, N.2    Lakic, D.3
  • 10
    • 41849098447 scopus 로고    scopus 로고
    • Cystatin C could be a replacement to serum creatinine for diagnosing and monitoring kidney function in children
    • 10 Narvaez-Sanchez, R., Gonzalez, L., Salamanca, A., et al. Cystatin C could be a replacement to serum creatinine for diagnosing and monitoring kidney function in children. Clin Biochem 41 (2008), 498–503.
    • (2008) Clin Biochem , vol.41 , pp. 498-503
    • Narvaez-Sanchez, R.1    Gonzalez, L.2    Salamanca, A.3
  • 11
    • 0030690056 scopus 로고    scopus 로고
    • The threat to medical-records research
    • 11 Melton, L.J. 3rd, The threat to medical-records research. N Engl J Med 337 (1997), 1466–1470.
    • (1997) N Engl J Med , vol.337 , pp. 1466-1470
    • Melton, L.J.1
  • 12
    • 79959777460 scopus 로고    scopus 로고
    • Mayo Clinic Antimicrobial Therapy: Quick Guide
    • 2nd ed. Oxford University Press Inc New York, NY
    • 12 Wilson, J., Estes, L., Mayo Clinic Antimicrobial Therapy: Quick Guide. 2nd ed., 2012, Oxford University Press Inc, New York, NY.
    • (2012)
    • Wilson, J.1    Estes, L.2
  • 13
    • 67651083250 scopus 로고    scopus 로고
    • Vancomycin therapeutic guidelines: a summary of consensus recommendations from the Infectious Diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists
    • 13 Rybak, M.J., Lomaestro, B.M., Rotschafer, J.C., et al. Vancomycin therapeutic guidelines: a summary of consensus recommendations from the Infectious Diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists. Clin Infect Dis 49 (2009), 325–327.
    • (2009) Clin Infect Dis , vol.49 , pp. 325-327
    • Rybak, M.J.1    Lomaestro, B.M.2    Rotschafer, J.C.3
  • 14
    • 84864603916 scopus 로고    scopus 로고
    • Impact of various body weights and serum creatinine concentrations on the bias and accuracy of the Cockcroft-Gault equation
    • 14 Winter, M.A., Guhr, K.N., Berg, G.M., Impact of various body weights and serum creatinine concentrations on the bias and accuracy of the Cockcroft-Gault equation. Pharmacotherapy 32 (2012), 604–612.
    • (2012) Pharmacotherapy , vol.32 , pp. 604-612
    • Winter, M.A.1    Guhr, K.N.2    Berg, G.M.3
  • 15
    • 0016916438 scopus 로고
    • Prediction of creatinine clearance from serum creatinine
    • 15 Cockcroft, D.W., Gault, M.H., Prediction of creatinine clearance from serum creatinine. Nephron 16 (1976), 31–41.
    • (1976) Nephron , vol.16 , pp. 31-41
    • Cockcroft, D.W.1    Gault, M.H.2
  • 16
    • 79951821210 scopus 로고    scopus 로고
    • Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary
    • 16 Liu, C., Bayer, A., Cosgrove, S.E., et al. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary. Clin Infect Dis 52 (2011), 285–292.
    • (2011) Clin Infect Dis , vol.52 , pp. 285-292
    • Liu, C.1    Bayer, A.2    Cosgrove, S.E.3
  • 17
    • 0003858901 scopus 로고    scopus 로고
    • The Six Sigma Handbook: A Complete Guide for Green Belts, Black Belts, and Managers at All Levels
    • 3rd ed. McGraw Hill New York, NY
    • 17 Pyzdek, T., Keller, P.A., The Six Sigma Handbook: A Complete Guide for Green Belts, Black Belts, and Managers at All Levels. 3rd ed., 2010, McGraw Hill, New York, NY.
    • (2010)
    • Pyzdek, T.1    Keller, P.A.2
  • 18
    • 33744839368 scopus 로고
    • Clinical calorimetry: tenth paper. A formula to estimate the approximate surface area if height and weight be known
    • 18 Du Bois, D., Du Bois, E., Clinical calorimetry: tenth paper. A formula to estimate the approximate surface area if height and weight be known. Arch Intern Med 17 (1916), 863–871.
    • (1916) Arch Intern Med , vol.17 , pp. 863-871
    • Du Bois, D.1    Du Bois, E.2
  • 19
    • 84863524855 scopus 로고    scopus 로고
    • Estimating glomerular filtration rate from serum creatinine and cystatin C [erratum in N Engl J Med. 2012;367(7):681]
    • 19 Inker, L.A., Schmid, C.H., Tighiouart, H., et al. Estimating glomerular filtration rate from serum creatinine and cystatin C [erratum in N Engl J Med. 2012;367(7):681]. N Engl J Med 367 (2012), 20–29.
    • (2012) N Engl J Med , vol.367 , pp. 20-29
    • Inker, L.A.1    Schmid, C.H.2    Tighiouart, H.3
  • 20
    • 33846153776 scopus 로고    scopus 로고
    • Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship
    • 20 Dellit, T.H., Owens, R.C., McGowan, J.E. Jr., et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 44 (2007), 159–177.
    • (2007) Clin Infect Dis , vol.44 , pp. 159-177
    • Dellit, T.H.1    Owens, R.C.2    McGowan, J.E.3
  • 21
    • 84884342549 scopus 로고    scopus 로고
    • KDIGO clinical practice guideline for acute kidney injury
    • 21 Kellum, J.A., Lameire, N., KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl 2 (2012), 1–138.
    • (2012) Kidney Int Suppl , vol.2 , pp. 1-138
    • Kellum, J.A.1    Lameire, N.2
  • 22
    • 84856937734 scopus 로고    scopus 로고
    • Linezolid in methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a randomized, controlled study
    • 22 Wunderink, R.G., Niederman, M.S., Kollef, M.H., et al. Linezolid in methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a randomized, controlled study. Clin Infect Dis 54 (2012), 621–629.
    • (2012) Clin Infect Dis , vol.54 , pp. 621-629
    • Wunderink, R.G.1    Niederman, M.S.2    Kollef, M.H.3
  • 23
    • 62049084378 scopus 로고    scopus 로고
    • Research Electronic Data Capture (REDCap)–a metadata-driven methodology and workflow process for providing translational research informatics support
    • 23 Harris, P.A., Taylor, R., Thielke, R., Payne, J., Gonzalez, N., Conde, J.G., Research Electronic Data Capture (REDCap)–a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 42 (2009), 377–381.
    • (2009) J Biomed Inform , vol.42 , pp. 377-381
    • Harris, P.A.1    Taylor, R.2    Thielke, R.3    Payne, J.4    Gonzalez, N.5    Conde, J.G.6
  • 24
    • 84875215709 scopus 로고    scopus 로고
    • Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics
    • 24 Kanda, Y., Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant 48 (2013), 452–458.
    • (2013) Bone Marrow Transplant , vol.48 , pp. 452-458
    • Kanda, Y.1
  • 25
    • 84862965924 scopus 로고    scopus 로고
    • Vancomycin AUC24/MIC ratio in patients with complicated bacteremia and infective endocarditis due to methicillin-resistant Staphylococcus aureus and its association with attributable mortality during hospitalization
    • 25 Brown, J., Brown, K., Forrest, A., Vancomycin AUC24/MIC ratio in patients with complicated bacteremia and infective endocarditis due to methicillin-resistant Staphylococcus aureus and its association with attributable mortality during hospitalization. Antimicrob Agents Chemother 56 (2012), 634–638.
    • (2012) Antimicrob Agents Chemother , vol.56 , pp. 634-638
    • Brown, J.1    Brown, K.2    Forrest, A.3
  • 26
    • 7444254040 scopus 로고    scopus 로고
    • Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections
    • 26 Moise-Broder, P.A., Forrest, A., Birmingham, M.C., Schentag, J.J., Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections. Clin Pharmacokinet 43 (2004), 925–942.
    • (2004) Clin Pharmacokinet , vol.43 , pp. 925-942
    • Moise-Broder, P.A.1    Forrest, A.2    Birmingham, M.C.3    Schentag, J.J.4
  • 27
    • 84958115367 scopus 로고    scopus 로고
    • Population pharmacokinetics of meropenem during continuous infusion in surgical ICU patients
    • 27 Kees, M.G., Minichmayr, I.K., Moritz, S., et al. Population pharmacokinetics of meropenem during continuous infusion in surgical ICU patients. J Clin Pharmacol 56:3 (2016), 307–315.
    • (2016) J Clin Pharmacol , vol.56 , Issue.3 , pp. 307-315
    • Kees, M.G.1    Minichmayr, I.K.2    Moritz, S.3
  • 28
    • 84930169502 scopus 로고    scopus 로고
    • Comparison of equations with estimate renal function to predict serum vancomycin concentration in patients with spinal cord injury–does the use of cystatin C improve accuracy?
    • 28 DeCarolis, D.D., Thorson, J.G., Marraffa, R.A., Clairmont, M.A., Kuskowski, M.A., Comparison of equations with estimate renal function to predict serum vancomycin concentration in patients with spinal cord injury–does the use of cystatin C improve accuracy?. Ther Drug Monit 36 (2014), 632–639.
    • (2014) Ther Drug Monit , vol.36 , pp. 632-639
    • DeCarolis, D.D.1    Thorson, J.G.2    Marraffa, R.A.3    Clairmont, M.A.4    Kuskowski, M.A.5
  • 29
    • 84874774161 scopus 로고    scopus 로고
    • Serum cystatin C is a major predictor of vancomycin clearance in a population pharmacokinetic analysis of patients with normal serum creatinine concentrations
    • 29 Chung, J.Y., Jin, S.J., Yoon, J.H., Song, Y.G., Serum cystatin C is a major predictor of vancomycin clearance in a population pharmacokinetic analysis of patients with normal serum creatinine concentrations. J Korean Med Sci 28 (2013), 48–54.
    • (2013) J Korean Med Sci , vol.28 , pp. 48-54
    • Chung, J.Y.1    Jin, S.J.2    Yoon, J.H.3    Song, Y.G.4
  • 30
    • 33748206739 scopus 로고    scopus 로고
    • Serum cystatin C for the prediction of glomerular filtration rate with regard to the dose adjustment of amikacin, gentamicin, tobramycin, and vancomycin
    • 30 Hermida, J., Tutor, J.C., Serum cystatin C for the prediction of glomerular filtration rate with regard to the dose adjustment of amikacin, gentamicin, tobramycin, and vancomycin. Ther Drug Monit 28 (2006), 326–331.
    • (2006) Ther Drug Monit , vol.28 , pp. 326-331
    • Hermida, J.1    Tutor, J.C.2
  • 31
    • 78249275544 scopus 로고    scopus 로고
    • Clearance of vancomycin during continuous infusion in intensive care unit patients: correlation with measured and estimated creatinine clearance and serum cystatin C
    • 31 Kees, M.G., Hilpert, J.W., Gnewuch, C., Kees, F., Voegeler, S., Clearance of vancomycin during continuous infusion in intensive care unit patients: correlation with measured and estimated creatinine clearance and serum cystatin C. Int J Antimicrob Agents 36 (2010), 545–548.
    • (2010) Int J Antimicrob Agents , vol.36 , pp. 545-548
    • Kees, M.G.1    Hilpert, J.W.2    Gnewuch, C.3    Kees, F.4    Voegeler, S.5
  • 32
    • 33947634111 scopus 로고    scopus 로고
    • Serum cystatin C as a better marker of vancomycin clearance than serum creatinine in elderly patients
    • 32 Okamoto, G., Sakamoto, T., Kimura, M., et al. Serum cystatin C as a better marker of vancomycin clearance than serum creatinine in elderly patients. Clin Biochem 40 (2007), 485–490.
    • (2007) Clin Biochem , vol.40 , pp. 485-490
    • Okamoto, G.1    Sakamoto, T.2    Kimura, M.3
  • 33
    • 75749128980 scopus 로고    scopus 로고
    • Population pharmacokinetic analysis of vancomycin using serum cystatin C as a marker of renal function
    • 33 Tanaka, A., Aiba, T., Otsuka, T., et al. Population pharmacokinetic analysis of vancomycin using serum cystatin C as a marker of renal function. Antimicrob Agents Chemother 54 (2010), 778–782.
    • (2010) Antimicrob Agents Chemother , vol.54 , pp. 778-782
    • Tanaka, A.1    Aiba, T.2    Otsuka, T.3
  • 34
    • 34248225362 scopus 로고    scopus 로고
    • Estimation of the initial dose setting of vancomycin therapy with use of cystatin C as a new marker of renal function
    • 34 Tanaka, A., Suemaru, K., Otsuka, T., et al. Estimation of the initial dose setting of vancomycin therapy with use of cystatin C as a new marker of renal function. Ther Drug Monit 29 (2007), 261–264.
    • (2007) Ther Drug Monit , vol.29 , pp. 261-264
    • Tanaka, A.1    Suemaru, K.2    Otsuka, T.3
  • 35
    • 35748969133 scopus 로고    scopus 로고
    • Hoek's formula, a cystatin C-based prediction formula for determining the glomerular filtration rate, is the most effective method for original adjusting the dosage of vancomycin
    • 35 Tanaka, A., Suemaru, K., Otsuka, T., et al. Hoek's formula, a cystatin C-based prediction formula for determining the glomerular filtration rate, is the most effective method for original adjusting the dosage of vancomycin. Int J Clin Pharmacol Ther 45 (2007), 592–597.
    • (2007) Int J Clin Pharmacol Ther , vol.45 , pp. 592-597
    • Tanaka, A.1    Suemaru, K.2    Otsuka, T.3
  • 36
    • 84933046086 scopus 로고    scopus 로고
    • Cystatin C as a potential biomarker for dosing of renally excreted drugs
    • 36 Brou, N.A., Jacqz-Aigrain, E., Zhao, W., Cystatin C as a potential biomarker for dosing of renally excreted drugs. Br J Clin Pharmacol 80 (2015), 20–27.
    • (2015) Br J Clin Pharmacol , vol.80 , pp. 20-27
    • Brou, N.A.1    Jacqz-Aigrain, E.2    Zhao, W.3
  • 37
    • 79955620196 scopus 로고    scopus 로고
    • Validation of the effectiveness of a vancomycin nomogram in achieving target trough concentrations of 15-20 mg/L suggested by the vancomycin consensus guidelines
    • 37 Kullar, R., Leonard, S.N., Davis, S.L., et al. Validation of the effectiveness of a vancomycin nomogram in achieving target trough concentrations of 15-20 mg/L suggested by the vancomycin consensus guidelines. Pharmacotherapy 31 (2011), 441–448.
    • (2011) Pharmacotherapy , vol.31 , pp. 441-448
    • Kullar, R.1    Leonard, S.N.2    Davis, S.L.3
  • 38
    • 62849095029 scopus 로고    scopus 로고
    • Pharmacokinetic issues for antibiotics in the critically ill patient
    • quiz 859
    • 38 Roberts, J.A., Lipman, J., Pharmacokinetic issues for antibiotics in the critically ill patient. Crit Care Med 37 (2009), 840–851 quiz 859.
    • (2009) Crit Care Med , vol.37 , pp. 840-851
    • Roberts, J.A.1    Lipman, J.2
  • 39
    • 29244442296 scopus 로고    scopus 로고
    • The pharmacokinetic and pharmacodynamic properties of vancomycin
    • 39 Rybak, M.J., The pharmacokinetic and pharmacodynamic properties of vancomycin. Clin Infect Dis 42:suppl 1 (2006), S35–S39.
    • (2006) Clin Infect Dis , vol.42 , pp. S35-S39
    • Rybak, M.J.1
  • 40
    • 66149108761 scopus 로고    scopus 로고
    • Prospectively validated dosing nomograms for maximizing the pharmacodynamics of vancomycin administered by continuous infusion in critically ill patients
    • 40 Pea, F., Furlanut, M., Negri, C., et al. Prospectively validated dosing nomograms for maximizing the pharmacodynamics of vancomycin administered by continuous infusion in critically ill patients. Antimicrob Agents Chemother 53 (2009), 1863–1867.
    • (2009) Antimicrob Agents Chemother , vol.53 , pp. 1863-1867
    • Pea, F.1    Furlanut, M.2    Negri, C.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.